Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
56 Cards in this Set
- Front
- Back
What is Cancer
|
A diseased state that arises due to violations of the social rules for cells
A large group of heterogeneous diseases |
|
Cancer Cells Characterized By
|
Cells that DO NOT respond to environmental signals for division and death
|
|
Initial Cancer
|
Tumors canot grow beyond a few millimeteres in volume without blood supply
The body is capable of destroying cancer cells |
|
How does cancer become a "Disease"
|
Angiogenesis - development of blood supply for tumor growth
Metastasis - migration throughout the body By outgrowing neighboring cells and destroy tissues |
|
Classes of Cancer
|
Benign
Malignant Metastatic |
|
Benign Cancer
|
Tumor that does NOT spread into surrounding tissue
|
|
Malignant
|
Tumor that spreads into other tissues
INVASIVE - primary tumor |
|
Metastatic
|
Movement of cancer cells from the PRIMARY tumor
Also the name for the tumor that forms from this process |
|
All Cancers are a result of
|
DNA Mutations
|
|
All cancers lose
|
Normal regulation of division and Death
|
|
Cancer results of mutation from _________ and ________
|
Environmental factors and Inherited genes
|
|
Cancer cases in the world and USA`
|
3 million and 1.5 million in USA
500,000 deaths per year |
|
Cancer genes normally participate in
|
Every system that promotes survival, propagation, death, and vascularization
|
|
Some Cancer gene specifics include
|
Cell cycle regulation
Mitosis Apoptosis DNA repair Telomerase activity DNA methylation Vascularization |
|
Chromosomal abnormalities and Cancer
|
Cancer cells usually have multiple chromosome abnormalities
|
|
Angiogenesis
|
The creation of blood vessels
|
|
_________ limits the ability of oxygen and nutrients to reach the center of a tumor mass
|
Diffusion
|
|
Metabolic Changes in cancer cells
|
Warburg Effect
Discovered in 1924 |
|
Warburg Effect
|
Cancer cells are addicted to glucose
Run high amounts of ANAEROBIC glycolysis pathway in AEROBIC conditions! |
|
Cancer Metabolism in absence of glucose
|
USE galactose and Fructose
|
|
Cancer Glycolysis and Metabolism is not performed to produce _______ but instead create intermediates for _________
|
ATP, cell division
|
|
Common Anticancer Drugs
|
DNA Replication Inhibitors
DNA Synthesis Inhibitors Mitosis Inhibitors |
|
Doxorubicin
|
DNA Replication inhibitor
Inhibits Topoisomerase |
|
Cyclophosphamide
|
DNA Replication Inhibitor
Cross links DNA so it cannot unwind |
|
5-Fluorouricil
|
DNA Synthesis Inhibitor
Inhibits dNTP synthesis |
|
Methotrexate
|
DNA Synthesis Inhibitor
Inhibits dNTP synthesis |
|
Taxol
|
Mitosis Inhibitor
Interfere with mitotic spindle fibers |
|
Vincristine
|
Interfere with Mitotic spindle fibers
Mitosis Inhibitor |
|
Copper
|
Found throughout the diet
|
|
Sources of Copper
|
Seeds, grains, nuts, beans, shellfish, and liver
|
|
Toxicity from Copper Overload
|
Redox activity
Reactive Oxygen Species Displaces other metal ions Peroxidize lipids Cleave DNA / RNA |
|
Copper Absorption
|
Absorbed in small intestine by HCTR I
|
|
Copper Transportation
|
ATOX-I (Metallochaperone)
Addition carriers and chaperones for specific enzymes |
|
Copper Proteins and Enzymes
|
Ceruloplasmin
Cytochrome C Oxidase Cu/Zn Superoxide Dismutase Metallothionin Lysyl Oxidase Matrixmetalloproteinase |
|
Ceruloplasmin
|
Seen also in iron metabolism
Primary copper transporter in the blood |
|
Copper Deficiency
|
Iron remains in the liver
Addition of copper bearing ceruloplasmin releases iron from the liver into the blood |
|
Cytochrome C Oxidase
|
Electron transport chain
Converts oxygen to water |
|
Cu/Zn Superoxide Dismutase
|
Converts Superoxide to peroxide
First enzyme to lose activity in copper deficient state |
|
Metallothionin
|
Metal Storage
Binds: Cu, Zn, Cd, Hg, Ag, Ni Cu Has highest affinity and displaces others |
|
Lysyl Oxidase
|
Cu is structural
Failure is found in MENKES disease Important for connective tissue architecture |
|
Matrixmetalloproteinase
|
Important enzyme in ANGIOGENESIS
|
|
Menkes Disease
|
Systemic copper deficiency
Fatal disorder: 3-4 years |
|
Menkes Disease Pathology
|
ATPase failure that prevents copper being moved out of cells
|
|
Menkes Disease Symptoms
|
Connective tissue abnormalities
Neuronal Degeneration Kinky hair Cells from patient accumulate copper |
|
Menkes disease therapy
|
Detection (MUSt BE AFTER BIRTH)
Administer Copper-Histidine -Main copper/amino acid complex found in serum Stabilize and improve disease -Experimental -Old survivor at time of report: 20 years |
|
Wilsons Disease
|
Liver Copper Overload
|
|
Wilsons Disease Pathophysiology
|
Copper elimination into the bile is impaired
Liver copper levels increase (copper deposition in other tissues) Ceruloplasmin levels decrease (can affect iron) |
|
Wilsons disease symptom
|
Hepatic symptoms
Neurological Symptoms Kayaer-Fleischer rings |
|
Wilsons disease therapy
|
Copper Elimination
Zinc maintenance Elimination via chelation and excretion in the urine |
|
Zinc Maintenance in Wilsons disease
|
DANGEROUS and CANNOT be used initially
Severe neurological damage is used during overload stage of disease Completely benign once acute copper storage phase passes |
|
Proteasome
|
Huge complex
Principle degradation machinery REPRESSES APOPTOSIS PROMOTES proliferation PROMOTES drug resistance |
|
Inhibition of Proteasome promotes ___________
|
APOPTOSIS
|
|
Copper and Cancer
|
Cancer tissues accumulate high levels of copper
|
|
Copper and Proteasome
|
Copper can DIRECTLY inhibit purified proteasome in vitro
|
|
Potency of copper inhibition
|
Organic Ligands alter potency of copper
Cells with high levels of copper are sensitive to ligand treatment |
|
Cure
|
Treatment with copper binding compounds to "detect" copper and form a proteasome inhibitor within tumor cells could prove an effective strategy for non-toxic chemotherapy.
|